Related Experiment Video
Updated: May 27, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Identification and development of 2,5-disubstituted oxadiazole as potential candidate for treatment of XDR and MDR
Ravi L Bakal1, Surendra G Gattani
1Department of Medicinal Chemistry, Wadhwani College of Pharmacy, Dhamangaon Road, Yavatmal, Maharashtra 445001, India. nddd2011@gmail.com
Abstract:
Tuberculosis, the infection on the verge of eradication once, is now a great threat to mankind. Emergence of MDR and XDR-TB synergised with HIV and other immune-compressive diseases have increased the life threatening capacities of the disease. A small molecule has been identified here, which showed potent anti-tubercular activity. The identified hit compound has also been proved active against nearly 25 clinical isolates comparable with isoniazid.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Discovery: Overview
